← Back

IDEX Corporation

IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, and custom mechanical and shaft seals. This segment also offers engineered hygienic mixers and valves, biocompatible medical devices and implantable products, air compressors and blowers, optical components and coatings, ultra-precision diamond tools, and laboratory and commercial equipment, as well as precision photonic solutions, technical ceramics, hermetic sealing products, porous material structures, and flow control solutions. The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, other fluid-handling pump modules, and systems; and provides flow monitoring and other services. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, and rescue tools; lifting bags and other components and systems; engineered stainless steel banding and clamping devices; and precision equipment for dispensing, metering, and mixing colorants and paints. The company was incorporated in 1987 and is headquartered in Northbrook, Illinois.

Price · split & dividend adjusted
News & notes moving IEX
IEX▲

SPX Technologies Leads Gas and Liquid Handling Stocks in Q2 Earnings

SPX Technologies reported second-quarter revenues of $679 million, up 22.9% year over year and beating analysts' expectations by 5.8%, making it the best performer among the 11 gas and liquid handling stocks tracked. The company also achieved the highest full-year guidance raise among its peers, and its stock has risen 12.2% since reporting to trade at $223.54. Parker-Hannifin posted revenues of $5.76 billion, up 9.8% year over year and exceeding estimates by 3.3%, with full-year EPS guidance also beating expectations. Graco was the slowest performer, with revenues of $590.6 million, up 3.3% year over year but missing estimates by 3%. Flowserve reported revenues of $1.17 billion, down 1.6% year over year but topping estimates by 0.9%, while IDEX posted revenues of $920.6 million, up 6.4% year over year and beating estimates by 1.7%.
SPXC ▲FLS GGG ▼IEX ▲PH ▲
Yahoo Finance·11dRead more ▾
IEX

IDEX shares rise 28.7% year to date as earnings and buyback fuel valuation debate

IDEX Corporation released second quarter and first half 2026 results and updated its share repurchase program, with the stock trading at US$230.45 and up 28.7% year to date. The most followed narrative on Simply Wall St places fair value at US$248 per share, suggesting the stock is 7.1% undervalued, driven by international expansion and technology adaptation in markets like pharmaceuticals and data centers. However, the current price-to-earnings ratio of 32.7x exceeds the fair ratio of 27.1x and the US Machinery industry average of 27.3x, indicating investors are already paying a premium. Bulls point to growing sales, earnings, and the buyback as signs of further upside, while bears highlight the higher starting price and risks including tariff-related cost pressure and softer demand in semiconductors and agriculture.
IEX
Simply Wall St·25dRead more ▾
IEX

Idex earnings expected to grow but Zacks model signals no clear beat

Idex is expected to report quarterly earnings of $2.10 per share on revenues of $902.43 million for the quarter ended June 2026, representing year-over-year growth of 1.5% and 4.3% respectively. The Zacks Earnings ESP for Idex stands at -0.67% with a Zacks Rank of #3, making it difficult to conclusively predict an earnings beat. Over the last four quarters, the company has beaten consensus EPS estimates each time. In the same industry, Crane is expected to post earnings of $1.66 per share on revenues of $706.06 million, with a positive Earnings ESP of +4.73% and a Zacks Rank of #2, suggesting a likely beat.
IEX CR
Zacks Investment Research·35dRead more ▾
IEX▼

StockStory Picks Natera as Cash-Producing Stock with Exciting Potential, Brushes Off Domino’s and IDEX

StockStory highlights Natera as a cash-producing stock with exciting potential, while advising investors to avoid Domino’s and IDEX. Natera, which develops genetic tests, saw tests processed grow 19.4% annually over two years, its adjusted operating margin expand by 15.7 percentage points, and free cash flow turn positive over five years. Domino’s is flagged for soft sales growth of 5.2% over seven years and an estimated 5.9% for the next 12 months, trading at 15.3 times forward earnings. IDEX is criticized for underperforming organic revenue, annual EPS growth of just 1.2% over two years, and eroding returns on capital, with shares at 25.2 times forward earnings.
DPZ ▼IEX ▼NTRA ▲
StockStory·47dRead more ▾
IEX▼

StockStory flags IDEX, Flex, and MSCI as profitable but risky stocks

StockStory identifies IDEX, Flex, and MSCI as profitable companies that warrant caution due to weakening fundamentals. IDEX, with a 20.7% trailing operating margin, has seen no organic revenue growth over two years and earnings per share rising only 1.2% annually. Flex, at a 4.9% margin, posted just 2.8% annual revenue growth and a weak 2.8% free cash flow margin over five years. MSCI, despite a 55.4% margin, shows negative return on equity. The report suggests better opportunities exist elsewhere.
FLEX ▼IEX ▼MSCI ▼
StockStory·64dRead more ▾
IEX▲

IDEX Corporation Stock Outperforms Industrial ETF Over Three Months and Year to Date

IDEX Corporation shares have risen 18.3% over the past three months, more than double the 9.5% gain of the State Street Industrial Select Sector SPDR ETF. The stock is up 26.4% year to date, exceeding the ETF's 16.6% advance, and has gained 28.5% over the past 52 weeks compared to the ETF's 27.2% return. Shares jumped 5.8% on April 29 after the company reported first-quarter 2026 sales of $887 million and adjusted diluted earnings per share of $2, both above expectations, and raised its full-year organic sales growth guidance to 3% to 4% and adjusted EPS guidance to $8.35 to $8.55. Rival Eaton Corporation plc has returned 32.4% year to date, outpacing IDEX, but its 52-week return of nearly 26% trails IDEX's performance. Analysts have a consensus Moderate Buy rating on IDEX with a mean price target of $241.23, a 7.2% premium to current levels.
IEX ▲
Barchart·69dRead more ▾
IEX▲2

IDEX declares $0.73 quarterly dividend

IDEX declared a regular quarterly cash dividend of $0.73 per share, matching the previous payout. The dividend is payable on July 24 to shareholders of record as of July 6, with an ex-dividend date of July 6. The forward yield is 1.31 percent. This marks the second consecutive quarter that the company has announced a dividend of $0.73.
IEX ▲
Seeking Alpha·69dRead more ▾
© 2026 MarketDXAsset